Support Appropriate Access to Cervical Cancer Testing to Protect Women's Health NOW.

Oct 04, 2017

Comments Needed!!!

USPSTF Draft Recommendation Could Undermine Safety and Efficacy of Cervical Cancer Prevention

ASCP is urging Pathologists and Laboratory Professionals to stand up for patient care and oppose a proposal from the U.S. Preventive Services Task Force (USPSTF).  The Task Force is proposing to eliminate its current recommendation of cervical co-testing every 5 years for women age 30-65.  The deadline for comments is October 9.

In responding to the proposed recommendation, ASCP has been working with the members of the Cytology Education Technology Consortium (CETC)(members identified below) to develop a consensus statement outlining the flaws with the USPSTF proposal. The CETC statement re-affirms recommendations outlined in a 2012 guideline developed by ASCP along with the American Cancer Society and American Society for Colposcopy and Cervical Pathology.  The ASC/ASCCP/ASCP guideline recommends co-testing using cervical cytology and HPV testing every five years as the most clinically appropriate approach for screening women age 30-65 for cervical cancer.

Instead of co-testing, the USPSTF proposes “screening every 3 years with cervical cytology alone or every 5 years with high-risk human papillomavirus (hrHPV) testing alone in women ages 30-65 years.”  ASCP believes the USPSTF recommendation would diminish the quality of patient care for women.  For more on the flaws with the USPSTF statement, see the CETC Consensus Statement.

To comment on the proposal, ASCP urges individuals to use the following link to view the USPSTF draft recommendation on cervical cancer screening

If you are willing to share your comments with ASCP, please email a copy to  Thank you.

Please feel free to forward this message to your colleagues…

===== ===== ===== ===== ===== ===== ===== ===== ===== ===== =====

*In addition to ASCP, the CETC includes the American Society of Cytopathology (ASC), the American Society for Cytotechnology (ASCT), the College of American Pathologists (CAP), the International Academy of Cytology (IAC) and the Papanicolaou Society of Cytopathology (PSC).